EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.3.1.24 | Alkalosis |
8283328 |
The effects of acidosis and alkalosis on long bone vascular resistance. |
causal interaction unassigned |
3 0 |
1.3.1.24 | Alzheimer Disease |
21241799 |
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment. |
causal interaction ongoing research unassigned |
3 1 0 |
1.3.1.24 | Alzheimer Disease |
21483094 |
Oxidative and nitrosative modifications of biliverdin reductase-a in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. |
causal interaction ongoing research unassigned |
3 2 0 |
1.3.1.24 | Alzheimer Disease |
22004509 |
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. |
causal interaction therapeutic application unassigned |
1 4 0 |
1.3.1.24 | Alzheimer Disease |
25206501 |
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain. |
causal interaction ongoing research therapeutic application unassigned |
1 1 3 0 |
1.3.1.24 | Alzheimer Disease |
26698666 |
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm. |
causal interaction unassigned |
2 0 |
1.3.1.24 | Alzheimer Disease |
29981845 |
Biliverdin reductase-A impairment links brain insulin resistance with increased A? production in an animal model of aging: Implications for Alzheimer disease. |
causal interaction therapeutic application unassigned |
4 1 0 |
1.3.1.24 | Alzheimer Disease |
30073505 |
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease. |
causal interaction ongoing research therapeutic application unassigned |
4 1 4 0 |
1.3.1.24 | Alzheimer Disease |
30738142 |
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease. |
causal interaction unassigned |
3 0 |
1.3.1.24 | Alzheimer Disease |
34224815 |
Biliverdin reductase as a target in drug research and development: Facts and hypotheses. |
causal interaction therapeutic application unassigned |
4 2 0 |